WO2006027584A3 - Vaccines against neisseria - Google Patents

Vaccines against neisseria Download PDF

Info

Publication number
WO2006027584A3
WO2006027584A3 PCT/GB2005/003459 GB2005003459W WO2006027584A3 WO 2006027584 A3 WO2006027584 A3 WO 2006027584A3 GB 2005003459 W GB2005003459 W GB 2005003459W WO 2006027584 A3 WO2006027584 A3 WO 2006027584A3
Authority
WO
WIPO (PCT)
Prior art keywords
fragment
variant
vaccines against
against neisseria
vaccines
Prior art date
Application number
PCT/GB2005/003459
Other languages
French (fr)
Other versions
WO2006027584A2 (en
Inventor
Christoph Marcel Tang
Rachel Mary Exley
Richard James Sim
Robert Charles Read
Original Assignee
Imp College Innovations Ltd
Christoph Marcel Tang
Rachel Mary Exley
Richard James Sim
Robert Charles Read
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp College Innovations Ltd, Christoph Marcel Tang, Rachel Mary Exley, Richard James Sim, Robert Charles Read filed Critical Imp College Innovations Ltd
Publication of WO2006027584A2 publication Critical patent/WO2006027584A2/en
Publication of WO2006027584A3 publication Critical patent/WO2006027584A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

A polypeptide comprising the amino acid sequence of any of SEQ ID Nos: 1 to 9 or a fragment or variant thereof or a fusion of such a fragment or variant, and polynucleotides encoding the same. The polypeptides or a fragment or variant thereof or a fusion of such a fragment or variant, and polynucleotides encoding the same, are useful as vaccines against Neisseria spp., and in particular prevent colonization of target tissue in an individual. Typically the vaccines are against N meningitidis or N gonorrhea.
PCT/GB2005/003459 2004-09-08 2005-09-08 Vaccines against neisseria WO2006027584A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0419918.8A GB0419918D0 (en) 2004-09-08 2004-09-08 Vaccine
GB0419918.8 2004-09-08

Publications (2)

Publication Number Publication Date
WO2006027584A2 WO2006027584A2 (en) 2006-03-16
WO2006027584A3 true WO2006027584A3 (en) 2006-06-15

Family

ID=33186661

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2005/003459 WO2006027584A2 (en) 2004-09-08 2005-09-08 Vaccines against neisseria

Country Status (2)

Country Link
GB (1) GB0419918D0 (en)
WO (1) WO2006027584A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3414331B1 (en) * 2016-02-10 2022-11-16 Engineered Antigens Inc. Slam polynucleotides and polypeptides and uses thereof
WO2023137320A2 (en) * 2022-01-11 2023-07-20 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating bacterial disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999057280A2 (en) * 1998-05-01 1999-11-11 Chiron Corporation Neisseria meningitidis antigens and compositions
WO1999061620A2 (en) * 1998-05-26 1999-12-02 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999057280A2 (en) * 1998-05-01 1999-11-11 Chiron Corporation Neisseria meningitidis antigens and compositions
WO1999061620A2 (en) * 1998-05-26 1999-12-02 Smithkline Beecham Biologicals S.A. Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 21 March 2000 (2000-03-21), "Neisseria meningitidis ORF 760 protein sequence SEQ ID NO:2606.", XP002361316, retrieved from EBI accession no. GSN:AAY75566 Database accession no. AAY75566 *
MORAND PHILIPPE C ET AL: "Type IV pilus retraction in pathogenic Neisseria is regulated by the PilC proteins", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 23, no. 9, 5 May 2004 (2004-05-05), pages 2009 - 2017, XP002359933, ISSN: 0261-4189 *

Also Published As

Publication number Publication date
WO2006027584A2 (en) 2006-03-16
GB0419918D0 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
NZ624533A (en) Novel immunotherapy against several tumors including neuronal and brain tumors
WO2005115306A3 (en) Keratin-binding polypeptides
WO2006074390A3 (en) Methods of treating obesity with combination therapeautics of igf-i fusion polypeptides
NZ597685A (en) Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
WO2006090810A3 (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
WO2007076162A3 (en) Antimicrobial cathelicidin peptides
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
WO2009069808A1 (en) Epha4 polypeptide having novel activity and use thereof
WO2006046239A3 (en) A thymus-specific protein
WO2009020553A3 (en) Chlamydia antigens
WO2006097432A3 (en) Keratin-binding desmoplakin polypeptide sequences
WO2004014937A3 (en) Thrombin peptide derivatives
WO2006027584A3 (en) Vaccines against neisseria
WO2004005317A3 (en) Thrombin peptide derivative dimers
EP1842911A4 (en) Hla-binding peptides, dna fragments encoding the same and recombinant vectors
ATE474589T1 (en) ANGIOGENIC PEPTIDES AND THEIR USES
EP1757687A4 (en) Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
WO2000058465A3 (en) Flint polypeptide analogs
WO2003015825A3 (en) Conjugate
WO2006067518A3 (en) Vaccines against neisseria meningitidis
WO2007069247A3 (en) Polynucleotides and polypeptide of human kv1.3, compositions comprising same and methods of using same
WO2007072032A3 (en) Neisseria meningitidis vaccines and their use
HK1131162A1 (en) Cytokine derivatives
WO2007073845A8 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
WO2001098355A3 (en) Cgi-69 compositions and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase